BR112023000233A2 - STRAIN OF THE SPECIES LACTICASEIBACILLUS RHAMNOSUS, ITS COMPOSITIONS AND ITS USE IN THE TREATMENT OF GENITOOURINARY INFECTIONS - Google Patents

STRAIN OF THE SPECIES LACTICASEIBACILLUS RHAMNOSUS, ITS COMPOSITIONS AND ITS USE IN THE TREATMENT OF GENITOOURINARY INFECTIONS

Info

Publication number
BR112023000233A2
BR112023000233A2 BR112023000233A BR112023000233A BR112023000233A2 BR 112023000233 A2 BR112023000233 A2 BR 112023000233A2 BR 112023000233 A BR112023000233 A BR 112023000233A BR 112023000233 A BR112023000233 A BR 112023000233A BR 112023000233 A2 BR112023000233 A2 BR 112023000233A2
Authority
BR
Brazil
Prior art keywords
lacticaseibacillus
compositions
treatment
infections
genitoourinary
Prior art date
Application number
BR112023000233A
Other languages
Portuguese (pt)
Inventor
Secondini Lorenzo
Lucia Randazzo Cinzia
Cianci Antonio
Cianci Stefano
Caggia Cinzia
Pino Alessandra
Catera Mietta
Original Assignee
Uriach Italy S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uriach Italy S R L filed Critical Uriach Italy S R L
Publication of BR112023000233A2 publication Critical patent/BR112023000233A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

CEPA DA ESPÉCIE LACTICASEIBACILLUS RHAMNOSUS, COMPOSIÇÕES DA MESMA E USO DA MESMA NO TRATAMENTO DE INFECÇÕES GENITOURINÁRIAS. A presente invenção refere-se a uma cepa bacteriana isolada e caracterizada pertencente à espécie Lacticaseibacillus rhamnosus, às composições da mesma e ao uso da mesma no tratamento de infecções e/ou inflamações genitourinárias.STRAIN OF THE LACTICASEIBACILLUS RHAMNOSUS SPECIES, ITS COMPOSITIONS AND ITS USE IN THE TREATMENT OF GENITOOURINARY INFECTIONS. The present invention refers to an isolated and characterized bacterial strain belonging to the Lacticaseibacillus rhamnosus species, its compositions and its use in the treatment of genitourinary infections and/or inflammations.

BR112023000233A 2020-07-09 2021-07-09 STRAIN OF THE SPECIES LACTICASEIBACILLUS RHAMNOSUS, ITS COMPOSITIONS AND ITS USE IN THE TREATMENT OF GENITOOURINARY INFECTIONS BR112023000233A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102020000016666A IT202000016666A1 (en) 2020-07-09 2020-07-09 NEW STRAIN OF THE LACTICASEIBACILLUS RHAMNOSUS SPECIES, ITS COMPOSITIONS AND THEIR USE IN THE TREATMENT OF GENITOURINARY INFECTIONS
PCT/IB2021/056187 WO2022009170A1 (en) 2020-07-09 2021-07-09 Novel strain of the species lacticaseibadllus rhamnosus, compositions thereof and use thereof in the treatment of genitourinary infections

Publications (1)

Publication Number Publication Date
BR112023000233A2 true BR112023000233A2 (en) 2023-03-14

Family

ID=72801836

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023000233A BR112023000233A2 (en) 2020-07-09 2021-07-09 STRAIN OF THE SPECIES LACTICASEIBACILLUS RHAMNOSUS, ITS COMPOSITIONS AND ITS USE IN THE TREATMENT OF GENITOOURINARY INFECTIONS

Country Status (7)

Country Link
US (1) US20230270797A1 (en)
EP (1) EP4178599A1 (en)
CN (1) CN116033914A (en)
AU (1) AU2021304480A1 (en)
BR (1) BR112023000233A2 (en)
IT (1) IT202000016666A1 (en)
WO (1) WO2022009170A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024028764A1 (en) * 2022-08-03 2024-02-08 Probioetna S.R.L. Lacticaseibacillus rhamnosus dsm 33960 and its use in a method for the prevention and treatment of urogenital tract dysbiosis
CN116200306B (en) * 2023-02-13 2023-12-19 微康益生菌(苏州)股份有限公司 Lactobacillus rhamnosus LRa16, and application and product thereof in preparation of medicines for treating genital tract infection
CN117384797B (en) * 2023-11-14 2024-04-05 完美（广东）日用品有限公司 Rhamnose cheese bacillus LRPerfectus158 and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2428214A1 (en) * 2010-09-14 2012-03-14 HSO Health Care GmbH Compositions for the vaginal and oral administration of lactobacillus and uses thereof

Also Published As

Publication number Publication date
EP4178599A1 (en) 2023-05-17
CN116033914A (en) 2023-04-28
AU2021304480A1 (en) 2023-02-09
IT202000016666A1 (en) 2022-01-09
US20230270797A1 (en) 2023-08-31
WO2022009170A1 (en) 2022-01-13

Similar Documents

Publication Publication Date Title
BR112023000233A2 (en) STRAIN OF THE SPECIES LACTICASEIBACILLUS RHAMNOSUS, ITS COMPOSITIONS AND ITS USE IN THE TREATMENT OF GENITOOURINARY INFECTIONS
BR112021017950A2 (en) Bacteria from the christensenellaceae family for the prevention and/or treatment of chronic inflammatory diseases and/or gastrointestinal inflammatory diseases and/or cancers
CO2018005217A2 (en) Composition comprising a bacterial strain of the genus enterococcus gallinarum
WO2018229236A3 (en) Compositions comprising bacterial strains
CO2017012829A2 (en) Compositions comprising bacterial strains
BR112018077266A2 (en) compositions comprising bacterial strains
BRPI0616960B8 (en) use of lactobacillus for the treatment of viral infections
BR112018015535B8 (en) MIXTURE, COMPOSITION, PLANT PROPAGATION MATERIAL, USE OF A MIXTURE AND CONTROL METHOD, SUPPRESSION OF PATHOGENS ON PLANTS OR PREVENTION OF INFECTION OF PLANTS BY PATHOGENS
MX2021002719A (en) Cannabinoids for the treatment of gram-positive infections including antibiotic-resistant bacterial strains.
Hirt et al. A D-enantiomer of the antimicrobial peptide GL13K evades antimicrobial resistance in the Gram positive bacteria Enterococcus faecalis and Streptococcus gordonii
MX2020010076A (en) Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof.
BR112018014654A2 (en) innovative strain of probiotic bacteria and compositions and uses thereof
BR112018003123A2 (en) composition, enema, isolated strain, method for treating and / or preventing a gastrointestinal condition, and use of an isolated bacterial composition, enema or one or more isolated strains
BR112015026773A2 (en) bacterial strains that have antimicrobial activity and biological control compositions comprising the same
MD3768284T2 (en) Compositions of entrecoccus flagellin for use in therapy
BR112019003427A2 (en) antibiotic compounds
WO2020085698A3 (en) Antimicrobial peptide derived from defense protein of octopus minor or fragment thereof, and antimicrobial composition comprising same
WO2018158306A8 (en) Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
ZA202002093B (en) Antibacterial compounds
WO2018176093A8 (en) Berberine alkaloid formulations in the prevention and/or treatment of infectious disease
CO2023016983A2 (en) Bacterial strains that have fungicidal activity, compositions that comprise them and use of these
BR112022005345A2 (en) IMMUNOGENIC COMPOSITIONS
BR112022003209A2 (en) Inhibition methods with microbial strains and antibiotics
AU2018257122A1 (en) Pharmaceutical composition comprising attenuated streptococcus pneumoniae strains and use thereof
MX2020012543A (en) Diltiazem for use in the treatment of microbial infections.